| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO & COO
1 company
Mark S Elliott last filed a Form 4 in September 2020, as CFO & COO at YCBD. Mark S Elliott's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 51,680 shares of YCBD. Net of sales, the YCBD filings show accumulation of 20,000 shares.
Mark S Elliott has 4 Form 4 filings on record from May 2018 to September 2020, all as CFO & COO at cbdMD (YCBD), 2018–2020.
The 5 reported transactions were 3 option or other derivative awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $20K and no sales.
The largest open-market purchase was 15,000 shares of YCBD at an average $1.00 on January 14, 2020, about $15K.
Shares as reported in the last Form 4 for each company; the most recent is from September 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.